Potential neurogenic and vascular roles of nitric oxide in migraine headache and aura

Headache

Volumn 39, Issue 2, 1999, Pages 118-124

  Myers, Daniel E ^a  

^a NONE   (United States)

Author keywords

Cerebral vasodilatation; Migraine aura; Nitric oxide; Spreading cortical depression

Indexed keywords

CYCLIC GMP; NITRATE; NITRIC OXIDE; NITRITE;

ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; EFFECTOR CELL; HEADACHE; HUMAN; HUMAN CELL; MIGRAINE; NEGATIVE FEEDBACK; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SECOND MESSENGER; SPREADING CORTICAL DEPRESSION; VASODILATATION;

EID: 0032988856     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1999.3902118.x     Document Type: Article

References (70)

1. WolfF HG. The cerebral circulation 11c. The action of amyl nitrite. Arch Neurol Psychiatry. 1929;22:686.
2. Sivertsen E. Glyceryltrinitrate as a problem in industry. Scand J Clin Lab Invest Suppl. 1984;173:81-84.
3. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport. 1993;4:1027-1030.
4. Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J. Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol. 1993;44:47-50.
5. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993;13:395-399.
6. Myers DE, Myers RA. A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache. 1995;35:197-199.
7. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94-100.
8. Scher W, Scher BM. A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate-induced asthma, 'hot-dog headache,' pugilistic Alzheimer's disease, and other disorders. Med Hypotheses. 1992;38:185-188.
9. Iversen HK, Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia. 1994;14:437-442.
10. Fozard JR. The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch Int Pharmacodyn Ther. 1995;329:111-119.
11. Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport. 1995; 6:1475-1479.
12. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet. 1997;349:401-402.
13. Kawamura J, Meyer JS. Headaches due to cerebrovascular disease. Med Clin North Am. 1991;75:617-630.
14. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993;116:187-202.
15. Pelligrino DA, Baughman VL, Koenig HM. Nitric oxide and the brain. Int Anesthesiol Clin. 1996; 34:113-132.
16. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke. 1997;28:1283-1288.
17. Iadecola C. Nitric oxide participates in the cerebrova-sodilation elicited from cerebellar fastigial nucleus. Am J Physiol. 1992;263:R1156-R1161.
18. Akgoren N, Dalgaard P, Lauritzen M. Cerebral blood flow increases evoked by electrical stimulation of rat cerebellar cortex: relation to excitatory synaptic activity and nitric oxide synthesis. Brain Res. 1996; 710:204-214.
19. Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998;17:7-23.
20. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
21. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 1987;139:19-30.
22. Schmidt HH. NO, CO and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 1992;307:102-107.
23. Price JM, Hellermann A. Inhibition of cGMP mediated relaxation in small rat coronary arteries by block of Ca++ activated K+ channels. Life Sci. 1997;61:1185-1192.
24. Ignarro LJ, Ross G, Tillisch J. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med. 1991;154:51-62.
25. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol. 1994;24:555-566.
26. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J. 1989;3:31-36.
27. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768-770.
28. Czapski G, Goldstein S. The role of the reactions of NO with superoxide and oxygen in biological systems: a kinetic approach. Free Rad Biol Med. 1995;19:785-794.
29. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther. 1990;254:872-876.
30. Iwamoto J, Yoshinaga M, Yang SP, Krasney E, Krasney J. Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep. J Appl Physiol. 1992;73:2226-2232.
31. Iadecola C. Li J, Ebner TJ, Xu X. Nitric oxide contributes to functional hyperemia in cerebellar cortex. Am J Physiol. 1995;268:R1153-R1162.
32. Pereira de Vasconcelos A, Baldwin RA, Wasterlain CG. Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proc Natl Acad Sci USA. 1995;92:3175-3179.
33. Stambach T, Haire K, Soni N, Booth J. Saturday night blue - a case of near fatal poisoning from the abuse of amyl nitrite. J Accident Emerg Med. 1997;14:339-340.
34. Leao AAP, Morrison RS. Propagation of spreading cortical depression. J Neurophysiol. 1945;8:33-45.
35. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994; 117:199-210.
36. Olesen J, Tfelt-Hansen P, Henriksen L, Larsen B. The common migraine attack may not be initiated by cerebral ischaemia. Lancet. 1981;2:438-440.
37. Olesen J. Cerebral blood flow in migraine with aura. Pathol. Biol. 1992;40:318-324.
38. Fabricius M, Akgoren N, Lauritzen M. Arginine-nitric oxide pathway and cerebrovascular regulation in cortical spreading depression. Am J Physiol. 1995; 269:H23-H29.
39. Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43(suppl 3):S21-S25.
40. Wahl M, Schilling L, Parsons AA, Kaumann A. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 1994;637:204-210.
41. Read SJ, Smith MI, Hunter AJ, Parsons AA. Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat. Cephalalgia. 1997;17:159-165.
42. Colonna DM, Meng W, Deal DD, Gowda M, Busija DW. Neuronal NO promotes cerebral cortical hyperernia during cortical spreading depression in rabbits. Am J Physiol. 1997;272:H1315-H1322.
43. Duckrow RB. A brief hypoperfusion precedes spreading depression if nitric oxide synthesis is inhibited. Brain Res. 1993;618:190-195.
44. Meng W, Colonna DM, Tobin JR, Busija DW. Nitric oxide and prostaglandins interact to mediate arteriolar dilation during cortical spreading depression. Am J Physiol. 1995;269:H176-H181.
45. Zhang ZG, Chopp M, Maynard KI, Moskowitz MA. Cerebral blood flow changes during cortical spreading depression are not altered by inhibition of nitric oxide synthesis. J Cereb Blood Flow Metab. 1994; 14:939-943.
46. Lauritzen M, Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab. 1992;12:223-229.
47. Obrenovitch TP, Zilkha E. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. Br J Pharmacol. 1996;117:931-937.
48. East SJ, Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway. Neurosci Lett. 1991;123:17-19.
49. Gault LM, Lin CW, LaManna JC, Lust WD. Changes in energy metabolites, cGMP and intracellular pH during cortical spreading depression. Brain Res. 1994;641:176-180.
50. Nei K, Matsuyama S, Shuntoh H, Tanaka C. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Res. 1996;728:105-110.
51. Mulsch A, Busse R, Mordvintcev PI, et al. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport. 1994;5:2325-2328.
52. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport. 1993;4:444-446.
53. Penix LP, Davis W, Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res. 1994;18:177-184.
54. Theard MA, Baughman VL, Wang Q, Pelligrino DA, Albrecht RF. The role of nitric oxide in modulating brain activity and blood flow during seizure. Neuroreport. 1995;6:921-924.
55. Przegalinski E, Baran L, Siwanowicz J. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci Lett. 1996;217:145-148.
56. Fagni L, Olivier M, Lafon-Cazal M, Bockaert J. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol Pharmacol. 1995; 47:1239-1247.
57. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 1992;8:653-662.
58. Rundfeldt C, Koch R, Richter A, Mervissen M, Gerecke U, Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol. 1995;274:73-81.
59. Segieth J, Getting SJ, Biggs CS, Whitton PS. Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neurosci Lett. 1995;200:101-104.
60. Kendrick KM, Guevara-Guzman R, de la Riva C, Christensen J, Ostergaard K, Emson PC. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur J Neurosci. 1996;8:2619-2634.
61. Sistiaga A, Miras-Portugal MT, Sanchez-Prieto J. Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway. Eur J Pharmacol. 1997;321:247-257.
62. Dalkara T, Moskowitz MA. Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischaemia. Int Rev Neurobiol. 1997;40:319-336.
63. Schumacher GA, Wolff HG. Experimental studies on headache: contrast of histamine headache with headache of migraine and that associated with hypertension. Arch Neurol Psychiatry. 1941;45:199-214.
64. Welch KM. Pathogenesis of migraine. Semin Neurol. 1997;17:335-341.
65. Young DB, Van Vliet BN. Migraine with aura: a vicious cycle perpetuated by potassium-induced vasoconstriction. Headache. 1992;32:24-34.
66. Skyhoj Olsen T, Friberg L, Lassen NA. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol. 1987;44:156-161.
67. La Spina I, Vignati A, Porazzi D. Basilar artery migraine: transcranial Doppler EEG and SPECT from the aura phase to the end. Headache. 1997;37:43-47.
68. Mashimo T, Pak M, Choe H, Inagaki Y, Yamamoto M, Yoshiya I. Effects of vasodilators guanethidine, nicardipine, nitroglycerin, and prostaglandin E1 on primary afferent nociceptors in humans. J Clin Pharmacol. 1997;37:330-335.
69. Lancelot E, Lecanu L, Revaud ML, Boulu RG, Plotkine M, Callebert J. Glutamate induces hydroxyl radical formation in vivo via activation of nitric oxide synthase in Sprague-Dawley rats. Neurosci Lett. 1998;242:131-134.
70. Knight JA. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci. 1997;27:11-25.